A Texas based dermatologist reveals the simple, cheap hack she uses to prevent irritating breakouts from the strap on her ...

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis ...

This finding was previously described as indicating a vehicle-dependent allergic contact dermatitis, presumably attributable to variation in the skin delivery of allergens in different vehicles.

AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, for treating moderate-to-severe atopic dermatitis (AD), also known as ...

ANB032 was well tolerated across all doses with no safety signals observed; AD trial and all further investment in ANB032 will be discontinued; Anticipate top-line Phase 2b data i ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

According to a 2021 review of previous research, vulvar itchiness is often the result of contact dermatitis. Contact dermatitis occurs when a person’s skin reacts to something that it touches ...

We retrospectively analyzed the results of specific IgE (sIgE) and total IgE (tIgE) in CU patients, explored the distribution patterns of these atopic markers in CU, and compared these data with those ...

resulting in clinical dermatitis. In addition, exposure to chemical and mechanical irritation may lead to increased percutaneous penetration of contact allergens. Therefore, the clinical scenario ...

ATOPIC dermatitis (AD) is a prevalent chronic childhood condition affecting up to 14% of children aged 0–4 years and approximately 9% of teenagers. Baricitinib, an oral selective Janus kinase (JAK) ...